机构:Beth Israel Deaconess Medical Center,Cardiovascular Division
Connie W. Tsao
Ramachandran S. Vasan
论文数: 0引用数: 0
h-index: 0
机构:Beth Israel Deaconess Medical Center,Cardiovascular Division
Ramachandran S. Vasan
机构:
[1] Beth Israel Deaconess Medical Center,Cardiovascular Division
[2] The Framingham Heart Study,undefined
来源:
Nature Reviews Endocrinology
|
2015年
/
11卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Endocrine and metabolic pathways are a rich ground in which to examine the prognostic significance of biomarkers of cardiovascular risk. Whereas numerous biomarkers for prediction of cardiovascular disease have emerged in the past decade, far fewer have transitioned into clinical practice. Will growth hormone fulfill its potential?